Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free ATHX Stock Alerts
NASDAQ:ATHX

Athersys (ATHX) Stock Price, News & Analysis

Athersys logo
Compare

About Athersys Stock (NASDAQ:ATHX)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
1.77 million shs
Market Capitalization
$833 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Athersys, Inc. was a biotechnology company focused on developing regenerative medicine therapies for serious and life-threatening conditions. Its principal platform was MultiStem, an investigational, off-the-shelf, allogeneic stem cell product intended to support tissue repair and modulate the immune system without requiring a patient-specific cell harvest.

The company evaluated MultiStem in clinical programs addressing conditions including ischemic stroke, acute respiratory distress syndrome, and other inflammatory or tissue-injury-related disorders. Athersys also pursued research collaborations and regional development arrangements, including a strategic relationship with Japan-based Healios K.K. to advance MultiStem programs in Japan.

Founded in 1995 and headquartered in Cleveland, Ohio, Athersys historically conducted its development activities primarily in the United States while working with international partners. The company entered Chapter 11 bankruptcy proceedings in 2023 and pursued transactions involving its assets and technology, substantially changing its corporate and operating status. Athersys was formerly listed on the Nasdaq under the symbol ATHX.

AI Generated. May Contain Errors.

Receive ATHX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Athersys and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ATHX Stock News Headlines

Athersys, Inc. (ATHXQ)
April 24, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/quote/ATHXQ/news/
Bankruptcy of once-promising Athersys winding down with assets sale
April 8, 2024  |  bizjournals.comhttps://www.bizjournals.com/cleveland/news/2024/04/08/athersys-bankruptcy-winding-down-assets-sale.html
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to trigger the next crash. The research firm Bernstein Research said this AI company has the power to crash the global economy for a decade, the CEO just issued a CODE RED in an internal memo warning employees they're dealing with a critical situation, and another company executive even implied they might need a government bailout. The last time I saw something like this was in 2008 when I predicted a stock market meltdown just three weeks before Lehman went under.tc pixel
September 25 at 1:00 AM  |  Paradigm Press (Ad)
Athersys to Sell Most Assets to Healios
January 8, 2024  |  marketwatch.comhttps://www.marketwatch.com/story/athersys-to-sell-most-assets-to-healios-91cc8b30
Athersys Reports Third Quarter 2023 Financial Results and Business Highlights
November 16, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/athersys-reports-third-quarter-2023-133000871.html?.tsrc=rss
Athersys shares migrate to Pink marketplace for broker-to-broker trading
October 23, 2023  |  bizjournals.comhttps://www.bizjournals.com/cleveland/inno/stories/news/2023/10/23/athersys-shares-migrate-to-pink-market.html
Athersys shares delisted by Nasdaq Stock Market
October 20, 2023  |  bizjournals.comhttps://www.bizjournals.com/cleveland/inno/stories/news/2023/10/20/athersys-shares-delisted-by-nasdaq-stock-market.html
Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives
October 16, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/athersys-extends-near-term-liquidity-205200866.html?.tsrc=rss
See More Headlines

ATHX Stock Analysis - Frequently Asked Questions

Athersys, Inc. (NASDAQ:ATHX) issued its earnings results on Monday, November, 15th. The biopharmaceutical company reported ($1.75) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($2.00) by $0.25. The biopharmaceutical company earned $4.79 million during the quarter.

Shares of Athersys reverse split on the morning of Monday, August 29th 2022.The 1-25 reverse split was announced on Monday, August 29th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 29th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of ATHX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Athersys investors own include Bank of America (BAC), Predictive Oncology (POAI), Ford Motor (F), Agenus (AGEN), JPMorgan Chase & Co. (JPM), Wells Fargo & Company (WFC) and Abbott Laboratories (ABT).

Company Calendar

Last Earnings
11/15/2021
Today
9/25/2026
Fiscal Year End
12/31/2026
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:ATHX
CIK
1368148
Web
www.athersys.com
Phone
(216) 431-9900
Fax
216-361-9495
Employees
24
Year Founded
1995

Profitability

EPS (Trailing Twelve Months)
($2.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$72.53 million
Net Margins
N/A
Pretax Margin
-46,304.93%
Return on Equity
N/A
Return on Assets
-223.03%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.06
Quick Ratio
0.06

Sales & Book Value

Annual Sales
$146 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.33) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
61,719,000
Free Float
61,700,000
Market Cap
$833 thousand
Optionable
No Data
Beta
-0.90

Social Links

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (NASDAQ:ATHX) was last updated on 9/25/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel
Bank of America: 'Digital Dollar Inevitable'
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel